Theranos CEO Holmes Barred from Operating Lab for 2 Years

July 8, 2016

(Reuters) – A U.S. health regulator has barred blood-testing company Theranos Inc’s founder and CEO, Elizabeth Holmes, from operating a lab for at least two years, the latest blow for a company that is under scrutiny for the accuracy and quality of its tests. The Centers for Medicare & Medicaid Services (CMS)revoked a key certificate for the company’s Newark, California lab, and terminated the facility’s approval to receive Medicare and Medicaid payments for all services, Theranos said late on Thursday.